[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560338":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":39,"collaborators":10,"id":41,"slug":10,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":42,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"University of Colorado, Denver","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Pediatric patients undergoing anesthesia",null,"Pediatric patients who are undergoing a surgical procedure with anesthesia. Patients will have type 1 diabetes and be wearing a continuous glucose monitor as part of routine care.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Erin Cobry, MD","CONTACT","3037242323","Erin.Cobry@cuanschutz.edu",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Barbara Davis Center","RECRUITING","Aurora","Colorado","80045","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-104.83192,39.72943,{"lat":31,"lon":30},[34,37],{"name":14,"role":15,"phone":35,"phoneExt":10,"email":36},"303-724-2323","erin.cobry@cuanschutz.edu",{"name":14,"role":38,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100560338",false,"NCT06575842","Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes","Inclusion Criteria:\n\n1. Participants will be 2 to 26 years of age at the time of enrollment.\n2. Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.\n3. Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.\n\nExclusion Criteria:\n\n1. Pregnancy.\n2. Currently using hydroxyurea.\n3. A condition that the investigator determines would prevent the patient from participation.","ALL","2 Years","26 Years",{"count":50,"type":51},120,"ESTIMATED","OBSERVATIONAL","This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.",[55],"Type 1 Diabetes",[57,58,59,60],"Anesthesia","Continuous glucose monitors","Accuracy","Pediatrics","2026-06-11",{"date":63,"type":64},"2026-06-12","ACTUAL",{"date":66,"type":64},"2024-08-21",{"date":68,"type":51},"2027-12-01",{"name":5,"class":6},1]